HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1800
https://www.valueinhealthjournal.com/article/S1098-3015(23)04930-6/fulltext
Title :
HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04930-6&doi=10.1016/j.jval.2023.09.1800
First page :
Section Title :
Open access? :
No
Section Order :
11236